Drug Halves Recurrence for Common Breast Cancer

All of the women in the new trial had undergone a standard treatment scenario. First, they received traditional chemotherapy and the drug Herceptin (trastuzumab) -- an antibody that targets HER2-positive cancer cells. Then they had surgery to remove any remaining cancer.

from WebMD Health https://ift.tt/2RCDP2C